$IMA News

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York

HC Wainwright & Co. Initiates Coverage On ImageneBio with Buy Rating, Announces Price Target of $28

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImageneBio Files Prospectus For Offering $200M Mixed Shelf

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate

ImageneBio Appoints Matt Robbins as General Counsel

ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York

Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target

ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update

ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate

ImageneBio $30 Million Private Placement Ignites Stock

ImageneBio Announces $30 Million Private Placement

ImageneBio shares are trading higher after the company announced it entered into a $30 million definitive securities purchase agreement with certain institutional investors in a private placement.

ImageneBio shares are trading higher after the company announced it entered into a $30 million definitive securities purchase agreement with certain institutional investors in a private placement.

ImageneBio Raises $30M Via Private Institutional Placement To Fund Hair Loss And Skin Disease Treatments

ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

ImageneBio Q4 EPS $(6.73) Misses $(1.44) Estimate

ImageneBio Insider Confidence Rewarded, Stock Hits US$76m Market Cap